WHWK
Whitehawk Therapeutics, Inc.Company with tickers: WHWK
CIK
1422142
CUSIP
00032Q104
Shares Outstanding
49,452,463
13F Activity (30d)
63 filings
61 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $7,145,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $8,788,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-23,522,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $73,016,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $1.84 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $1.83 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |